- Home
- Publications
- Publication Search
- Publication Details
Title
Somatostatin receptor ligands in the treatment of acromegaly
Authors
Keywords
Somatostatin receptor ligands, Acromegaly, Somatostatin receptors, Octreotide, Lanreotide, Pasireotide
Journal
Pituitary
Volume 20, Issue 1, Pages 100-108
Publisher
Springer Nature
Online
2017-02-07
DOI
10.1007/s11102-017-0791-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly
- (2016) Iulia Potorac et al. ENDOCRINE-RELATED CANCER
- Low beta-arrestin expression correlates with the responsiveness to long-term somatostatin analog treatment in acromegaly
- (2016) Federico Gatto et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Pasireotide for the treatment of acromegaly
- (2016) Luiz Eduardo Wildemberg et al. EXPERT OPINION ON PHARMACOTHERAPY
- Current and Emerging Aspects of Diabetes Mellitus in Acromegaly
- (2016) Stefano Frara et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomas
- (2015) Raúl M. Luque et al. CANCER LETTERS
- Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study
- (2015) Donato Iacovazzo et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Filamin A (FLNA) Plays an Essential Role in Somatostatin Receptor 2 (SST2) Signaling and Stabilization After Agonist Stimulation in Human and Rat Somatotroph Tumor Cells
- (2014) E. Peverelli et al. ENDOCRINOLOGY
- Acromegaly Clinical Trial Methodology Impact on Reported Biochemical Efficacy Rates of Somatostatin Receptor Ligand Treatments: A Meta-Analysis
- (2014) John D. Carmichael et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Acromegaly: An Endocrine Society Clinical Practice Guideline
- (2014) Laurence Katznelson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study
- (2014) A. Colao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Somatostatin receptor ligands and resistance to treatment in pituitary adenomas
- (2014) Daniel Cuevas-Ramos et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial
- (2014) Mônica R Gadelha et al. Lancet Diabetes & Endocrinology
- Management of hyperglycemia associated with pasireotide (SOM230): Healthy volunteer study
- (2013) Astrid Breitschaft et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- β-Arrestin 1 and 2 and G Protein-Coupled Receptor Kinase 2 Expression in Pituitary Adenomas: Role in the Regulation of Response to Somatostatin Analogue Treatment in Patients With Acromegaly
- (2013) Federico Gatto et al. ENDOCRINOLOGY
- Expression of somatostatin receptors, SSTR2A and SSTR5, in 108 endocrine pituitary tumors using immunohistochemical detection with new specific monoclonal antibodies
- (2013) Laura Chinezu et al. HUMAN PATHOLOGY
- Hyperglycemia Associated With Pasireotide: Results From a Mechanistic Study in Healthy Volunteers
- (2013) Robert R. Henry et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in Somatotroph Adenomas Assessed by Monoclonal Antibodies Was Reduced by Octreotide and Correlated With the Acute and Long-Term Effects of Octreotide
- (2013) Olivera Casar-Borota et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Endoscopic vs Microsurgical Transsphenoidal Surgery for Acromegaly: Outcomes in a Concurrent Series of Patients Using Modern Criteria For Remission
- (2013) Robert M. Starke et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Tumor Shrinkage With Lanreotide Autogel 120 mg as Primary Therapy in Acromegaly: Results of a Prospective Multicenter Clinical Trial
- (2013) Philippe J. Caron et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cyclic adenosine 3′-5′-monophosphate (cAMP) exerts proliferative and anti-proliferative effects in pituitary cells of different types by activating both cAMP-dependent protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac)
- (2013) E. Vitali et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Illuminating somatostatin analog action at neuroendocrine tumor receptors
- (2013) Jean Claude Reubi et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- AIP expression in sporadic somatotropinomas is a predictor of the response to octreotide LAR therapy independent of SSTR2 expression
- (2012) Leandro Kasuki et al. ENDOCRINE-RELATED CANCER
- Somatostatin Analogs Modulate AIP in Somatotroph Adenomas: The Role of the ZAC1 Pathway
- (2012) Harvinder S. Chahal et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Immunoreactivity Score Using an Anti-sst2A Receptor Monoclonal Antibody Strongly Predicts the Biochemical Response to Adjuvant Treatment with Somatostatin Analogs in Acromegaly
- (2012) Federico Gatto et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Novel pathway for somatostatin analogs in patients with acromegaly
- (2012) Mônica R. Gadelha et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly
- (2011) Stine Lyngvi Fougner et al. CLINICAL ENDOCRINOLOGY
- Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly
- (2011) Ansgar Heck et al. CLINICAL ENDOCRINOLOGY
- Resistance to Somatostatin Analogs in Acromegaly
- (2011) Annamaria Colao et al. ENDOCRINE REVIEWS
- The role of somatostatin and dopamine D2 receptors in endocrine tumors
- (2011) Federico Gatto et al. ENDOCRINE-RELATED CANCER
- Effects of high-dose octreotide LAR on glucose metabolism in patients with acromegaly inadequately controlled by conventional somatostatin analog therapy
- (2011) Gherardo Mazziotti et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Endoscopic Transsphenoidal Surgery for Acromegaly: Remission Using Modern Criteria, Complications, and Predictors of Outcome
- (2011) John A. Jane et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Comparison of octreotide LAR and lanreotide autogel as post-operative medical treatment in acromegaly
- (2011) Yasemin Tutuncu et al. Pituitary
- Clinical Characteristics and Therapeutic Responses in Patients with Germ-LineAIPMutations and Pituitary Adenomas: An International Collaborative Study
- (2010) Adrian F. Daly et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- ZAC1 target genes and pituitary tumorigenesis
- (2010) Marily Theodoropoulou et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Pituitary somatostatin receptor signaling
- (2010) Anat Ben-Shlomo et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial
- (2009) Andrea Giustina et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Identification and Characterization of Two Novel Truncated but Functional Isoforms of the Somatostatin Receptor Subtype 5 Differentially Present in Pituitary Tumors
- (2009) Mario Durán-Prado et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Agonist-Biased Signaling at the sst2A Receptor: The Multi-Somatostatin Analogs KE108 and SOM230 Activate and Antagonize Distinct Signaling Pathways
- (2009) Renzo Cescato et al. MOLECULAR ENDOCRINOLOGY
- Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel® therapy: a randomized, placebo-controlled, multicenter study with a 52 week open extension
- (2009) Shlomo Melmed et al. Pituitary
- Avaliação do metabolismo da glicose em pacientes acromegálicos antes e após tratamento com octreotide LAR
- (2008) Lívia L. Correa et al. Arquivos Brasileiros de Endocrinologia e Metabologia
- Octreotide LARvs.surgery in newly diagnosed patients with acromegaly: a randomized, open-label, multicentre study
- (2008) Annamaria Colao et al. CLINICAL ENDOCRINOLOGY
- Quantitative analysis of somatostatin receptor subtypes (1–5) gene expression levels in somatotropinomas and correlation to in vivo hormonal and tumor volume responses to treatment with octreotide LAR
- (2008) Giselle F Taboada et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Selective Loss of Somatostatin Receptor 2 in Octreotide-Resistant Growth Hormone-Secreting Adenomas
- (2008) Ursula Plöckinger et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Differential Effects of Octreotide and Pasireotide on Somatostatin Receptor Internalization and Traffickingin Vitro
- (2008) Sarah Lesche et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cell Growth Inhibition and Functioning of Human Somatostatin Receptor Type 2 Are Modulated by Receptor Heterodimerization
- (2008) Michael Grant et al. MOLECULAR ENDOCRINOLOGY
- Molecular mechanisms of the antiproliferative activity of somatostatin receptors (SSTRs) in neuroendocrine tumors
- (2007) Tullio Florio Frontiers in Bioscience-Landmark
- Somatostatin agonists for treatment of acromegaly
- (2007) Anat Ben-Shlomo et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started